Contact

All Stories

  1. Application of Cyborgs and Enhancement Technology in Biomedical Engineering    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  2. CD4 T follicular helper cells in HIV    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  3. How Artificial Intelligence Is Contributing to the Control of the COVID-19 Pandemic    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo

  4. Qualitative Study of Methamphetamine Users Perspectives on Drug Subsistence Barriers and Facilitators    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo

  5. Scientific Relevance and Future of Digital Immortality and Virtual Humans    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  6. Future of Psychoactive Drugs in the Time of Cutting-Edge Technologies

    Article • May 2021, Authorea, Inc.

    Prof.Dr. Daniel Cebo

  7. Internet drug trading: national review of new online drug markets for young people

    Article • May 2021, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  8. Crystal Meth and HIV / AIDS: A Pilot Study of Behavioral and Clinical Correlates

    Article • March 2021, Authorea, Inc.

    Prof.Dr. Daniel Cebo

  9. Review of "HIV Infection and Cardiovascular Disease"

    Article • March 2020, Publons

    Prof.Dr. Daniel Cebo, Daniel Cebo

  10. Culture of Isolated Human Adipocytes and Isolated Adipose Tissue

    Article • October 2011, Springer Science + Business Media

    Prof.Dr. Daniel Cebo

  11. Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease

    Article • Neurogenetics, September 2009, Springer Science + Business Media

    Professor Ferdinand von Eggeling, Prof.Dr. Daniel Cebo, Daniel Cebo

  12. EPRA International Journal of Research & Development (IJRD)

    Article • EPRA International Journal of Research & Development (IJRD), EPRA JOURNALS

    Prof.Dr. Daniel Cebo